Evidence map›Paper›PMID 23860259›Full record

ReviewBiochimica et biophysica acta2013

Peptidylarginine deiminases in citrullination, gene regulation, health and pathogenesis.

Shu Wang, Yanming Wang

Abstract readReview
In one paragraph

Review in Biochimica et biophysica acta, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 169 papers.

0numbers the graph read from it
0cells of the map it votes in
169citing papers in PubMed
11.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

169 citing papers in PubMed, 282 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Review
  16. Article
  17. Review
  18. Review
  19. Article
  20. Review

109 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Shu WangGraduate Program in Biochemistry and Molecular Biology, Pennsylvania State University, University Park, PA, 16802 USA; Center for Eukaryotic Gene Regulation, Pennsylvania State University, University Park, PA, 16802 USA; Department of Biochemistry and Molecular Biology, Pennsylvania State University, University Park, PA, 16802 USA.
Yanming Wang
Pennsylvania State University · US

Funding

Molecular mechanisms in the regulation of p53 functions by PAD4R01CA136856 · NCI · PENNSYLVANIA STATE UNIVERSITY, THE · PI WANG, YANMING · 2009 to 2013
$1.3M
NCI NIH HHS R01 CA136856
6 · The paper itself

Abstract

Peptidylarginine deiminases are a family of enzymes that mediate post-translational modifications of protein arginine residues by deimination or demethylimination to produce citrulline. In vitro, the activity of PADs is dependent on calcium and reductive reagents carrying a free sulfhydryl group. The discovery that PAD4 can target both arginine and methyl-arginine for citrullination about 10years ago renewed our interest in studying this family of enzymes in gene regulation and their physiological functions. The deregulation of PADs is involved in the etiology of multiple human diseases, including cancers and autoimmune disorders. There is a growing effort to develop isoform specific PAD inhibitors for disease treatment. However, the regulation of the activity of PADs in vivo remains largely elusive, and we expect that much will be learned about the role of these enzymes in a normal life cycle and under pathology conditions.

Indexed as

Gene Expression RegulationAutoimmune DiseasesCitrullineHumansHydrolasesProtein-Arginine DeiminasesProtein Processing, Post-TranslationalCitrullineHydrolasesProtein-Arginine DeiminasesAutoimmunityCancerGene regulationHistonePeptidylarginine deiminase

Identifiers

PMID23860259
PMCPMC3775966
OpenAlexW1985820548

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.